HomeCompareZBH vs PODD

ZBH vs PODD: Dividend Comparison 2026

ZBH yields 1.08% · PODD yields 0.96%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZBH wins by $195.00 in total portfolio value
10 years
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →
PODD
PODD
● Live price
0.96%
Share price
$208.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.34
Full PODD calculator →

Portfolio growth — ZBH vs PODD

📍 ZBH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZBHPODD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZBH + PODD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZBH pays
PODD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
PODD
Annual income on $10K today (after 15% tax)
$81.73/yr
After 10yr DRIP, annual income (after tax)
$86.99/yr
At 15% tax rate, ZBH beats the other by $13.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZBH + PODD for your $10,000?

ZBH: 50%PODD: 50%
100% PODD50/50100% ZBH
Portfolio after 10yr
$21.1K
Annual income
$110.49/yr
Blended yield
0.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PODD right now

ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
PODD
Analyst Ratings
36
Buy
10
Hold
3
Sell
Consensus: Buy
Price Target
$357.25
+71.7% upside vs current
Range: $286.00 — $435.00
Altman Z
7.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZBH buys
0
PODD buys
0
No recent congressional trades found for ZBH or PODD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZBHPODD
Forward yield1.08%0.96%
Annual dividend / share$0.96$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.2%0%
Portfolio after 10y$21.2K$21.0K
Annual income after 10y$118.64$102.34
Total dividends collected$1.1K$995.00
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusHoldBuy
Analyst price target$105.60$357.25

Year-by-year: ZBH vs PODD ($10,000, DRIP)

YearZBH PortfolioZBH Income/yrPODD PortfolioPODD Income/yrGap
1← crossover$10,809$108.54$10,796$96.15+$13.00ZBH
2$11,675$109.86$11,649$97.01+$26.00ZBH
3$12,603$111.13$12,562$97.83+$41.00ZBH
4$13,598$112.34$13,540$98.60+$58.00ZBH
5$14,663$113.51$14,587$99.32+$76.00ZBH
6$15,804$114.62$15,708$100.00+$96.00ZBH
7$17,026$115.69$16,909$100.64+$117.00ZBH
8$18,335$116.71$18,193$101.24+$142.00ZBH
9$19,736$117.70$19,569$101.81+$167.00ZBH
10$21,236$118.64$21,041$102.34+$195.00ZBH

ZBH vs PODD: Complete Analysis 2026

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →

PODDStock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Full PODD Calculator →
📬

Get this ZBH vs PODD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZBH vs SCHDZBH vs JEPIZBH vs OZBH vs KOZBH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.